Get started
KALA BIO INC COM USD0.001 (POST REV SPLIT)KALA BIO INC COM USD0.001 (POST REV SPLIT)KALA BIO INC COM USD0.001 (POST REV SPLIT)

KALA BIO INC COM USD0.001 (POST REV SPLIT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0JQ2 chart


Full chart

0JQ2 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪27.66 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−12.475 USD
Net income (FY)
‪−42.20 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪3.77 M‬
Beta (1Y)
0.77

Employees


Employees (FY)
43
Change (1Y)
+9 +26.47%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−981.37 K‬ USD

About KALA BIO, Inc.


Sector
Health Technology
CEO
Mark T. Iwicki
Headquarters
Arlington
Website
kalarx.com
Founded
2009
FIGI
BBG00JVXDBW7
KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0JQ2 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0JQ2 is 6.030 USD — it has decreased by −1.94% in the past 24 hours. Watch KALA BIO INC COM USD0.001 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange KALA BIO INC COM USD0.001 (POST REV SPLIT) stocks are traded under the ticker 0JQ2.
0JQ2 stock has fallen by −14.70% compared to the previous week, the month change is a −11.35% fall, over the last year KALA BIO INC COM USD0.001 (POST REV SPLIT) has showed a −13.85% decrease.
We've gathered analysts' opinions on KALA BIO INC COM USD0.001 (POST REV SPLIT) future price: according to them, 0JQ2 price has a max estimate of 15.00 USD and a min estimate of 15.00 USD. Watch 0JQ2 chart and read a more detailed KALA BIO INC COM USD0.001 (POST REV SPLIT) stock forecast: see what analysts think of KALA BIO INC COM USD0.001 (POST REV SPLIT) and suggest that you do with its stocks.
0JQ2 reached its all-time high on Mar 19, 2018 with the price of 905.000 USD, and its all-time low was 4.730 USD and was reached on Jun 26, 2024. View more price dynamics on 0JQ2 chart.
See other stocks reaching their highest and lowest prices.
0JQ2 stock is 2.48% volatile and has beta coefficient of 0.77. Track KALA BIO INC COM USD0.001 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is KALA BIO INC COM USD0.001 (POST REV SPLIT) there?
Today KALA BIO INC COM USD0.001 (POST REV SPLIT) has the market capitalization of ‪27.29 M‬, it has decreased by −10.31% over the last week.
Yes, you can track KALA BIO INC COM USD0.001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
KALA BIO INC COM USD0.001 (POST REV SPLIT) is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
0JQ2 earnings for the last quarter are −1.93 USD per share, whereas the estimation was −2.43 USD resulting in a 20.58% surprise. The estimated earnings for the next quarter are −2.28 USD per share. See more details about KALA BIO INC COM USD0.001 (POST REV SPLIT) earnings.
KALA BIO INC COM USD0.001 (POST REV SPLIT) revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
0JQ2 net income for the last quarter is ‪−8.95 M‬ USD, while the quarter before that showed ‪−9.58 M‬ USD of net income which accounts for 6.57% change. Track more KALA BIO INC COM USD0.001 (POST REV SPLIT) financial stats to get the full picture.
No, 0JQ2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 43.00 employees. See our rating of the largest employees — is KALA BIO INC COM USD0.001 (POST REV SPLIT) on this list?
Like other stocks, 0JQ2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KALA BIO INC COM USD0.001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KALA BIO INC COM USD0.001 (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KALA BIO INC COM USD0.001 (POST REV SPLIT) stock shows the sell signal. See more of KALA BIO INC COM USD0.001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.